Correlation Between NLS Pharmaceutics and Sirona Biochem
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Sirona Biochem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Sirona Biochem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Sirona Biochem Corp, you can compare the effects of market volatilities on NLS Pharmaceutics and Sirona Biochem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Sirona Biochem. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Sirona Biochem.
Diversification Opportunities for NLS Pharmaceutics and Sirona Biochem
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NLS and Sirona is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Sirona Biochem Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sirona Biochem Corp and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Sirona Biochem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sirona Biochem Corp has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Sirona Biochem go up and down completely randomly.
Pair Corralation between NLS Pharmaceutics and Sirona Biochem
Assuming the 90 days horizon NLS Pharmaceutics is expected to generate 3.63 times less return on investment than Sirona Biochem. In addition to that, NLS Pharmaceutics is 3.26 times more volatile than Sirona Biochem Corp. It trades about 0.02 of its total potential returns per unit of risk. Sirona Biochem Corp is currently generating about 0.26 per unit of volatility. If you would invest 3.99 in Sirona Biochem Corp on September 4, 2024 and sell it today you would earn a total of 1.58 from holding Sirona Biochem Corp or generate 39.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
NLS Pharmaceutics AG vs. Sirona Biochem Corp
Performance |
| Timeline |
| NLS Pharmaceutics |
| Sirona Biochem Corp |
NLS Pharmaceutics and Sirona Biochem Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NLS Pharmaceutics and Sirona Biochem
The main advantage of trading using opposite NLS Pharmaceutics and Sirona Biochem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Sirona Biochem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sirona Biochem will offset losses from the drop in Sirona Biochem's long position.| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
| Sirona Biochem vs. Pmv Pharmaceuticals | Sirona Biochem vs. MediciNova | Sirona Biochem vs. Pharvaris BV | Sirona Biochem vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |